Hong Liu
28Patents
2h-index
105Co-inventors
56Inventor score
Filing activity: Dec 2, 2005 → Jul 13, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9751882B2 | Diaryl[A, G]quinolizidine compound, preparation method therefor, pharmaceutical composition, and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US9045491B2 | Thienyl [3,2-D] pyrimidin-4-one compounds, preparation method, pharmaceutical compositions and use thereof | Human Necessities | 3 | Active |
| US10618900B2 | 5-aromatic alkynyl substituted benzamide compound and preparation method, pharmaceutical composition, and use thereof | Chemistry; Metallurgy | 1 | Active |
| US9155744B2 | Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries | Chemistry; Metallurgy | 1 | Active |
| US10927107B2 | Phenyl [a]indole[2,3-g]quinolizine compounds, preparation method therefor, pharmaceutical composition, and applications thereof | Chemistry; Metallurgy | 0 | Active |
| US11291748B2 | Embolism material for blood vessel, preparation method therefor and use thereof in preparation of drugs | Human Necessities | 0 | Active |
| US9737517B2 | Pharmaceutical use of hexahydro-dibenzo[a,g]quinolizine compounds | Human Necessities | 0 | Active |
| US8329922B2 | Crystalline sodium atorvastatin | Human Necessities | 0 | Active |
| US9359372B2 | Hexahydrodibenzo[a,g]quinolizine compound, preparation method thereof, pharmaceutical composition and use thereof | Chemistry; Metallurgy | 0 | Active |
| US10611774B2 | Salt form of DPPIV inhibitor and preparation method thereof | Chemistry; Metallurgy | 0 | Active |
| US8440712B2 | Crystalline sodium atorvastatin | Human Necessities | 0 | Active |
| US10167299B2 | 1-(3-aminopropyl) substituted cyclic amine compounds, preparation method therefor, and pharmaceutical compositions and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12152017B2 | Ketoamide compound and preparation method, pharmaceutical composition, and use thereof | Chemistry; Metallurgy | 0 | Active |
| US10800776B2 | Fluorine-containing triazolopyridine, and manufacturing method, pharmaceutical composition, and application thereof | Human Necessities | 0 | Active |
| US10882818B1 | P-bromoaniline cassic acid ester with antibacterial activity and a method of preparing the same | Chemistry; Metallurgy | 0 | Active |
| US10392401B2 | Crystal form A of compound and preparation method thereof | Chemistry; Metallurgy | 0 | Active |
| US7662860B2 | 3D-structure model of SARS coronavirus 3CL protease and anti-SARS drugs | Human Necessities | 0 | Active |
| US8017647B2 | Crystalline sodium atorvastatin | Human Necessities | 0 | Active |
| US10836743B2 | Fluorinated cyclopropylamine compound, preparation method therefor, pharmaceutical composition thereof, and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11873292B2 | Trans-indoline cyclopropylamine chemical compound, and method for preparation, pharmaceutical composition, and use thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US12397008B2 | Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries | Chemistry; Metallurgy | 0 | Active |
| US8097734B2 | Crystalline sodium atorvastatin | Human Necessities | 0 | Active |
| US10875883B2 | Method for synthesizing novel chiral ligand, metal chelate, a variety of non-natural amino acids, maraviroc and key intermediate thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US9637454B2 | Fluorine substituted cyclic amine compounds and preparation methods, pharmaceutical compositions, and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10550143B2 | C,O-spiro aryl glycoside compounds, preparation therefor and use thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.